195 related articles for article (PubMed ID: 30405615)
1. Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.
Pan E; Feng F; Li P; Yang Q; Ma X; Wu C; Zhao J; Yan H; Chen R; Chen L; Sun C
Front Immunol; 2018; 9():2415. PubMed ID: 30405615
[TBL] [Abstract][Full Text] [Related]
2. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.
Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C
J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070
[TBL] [Abstract][Full Text] [Related]
3. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
4. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.
Velu V; Kannanganat S; Ibegbu C; Chennareddi L; Villinger F; Freeman GJ; Ahmed R; Amara RR
J Virol; 2007 Jun; 81(11):5819-28. PubMed ID: 17376899
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
7. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
[TBL] [Abstract][Full Text] [Related]
8. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm.
Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P
AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867
[TBL] [Abstract][Full Text] [Related]
12. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
[TBL] [Abstract][Full Text] [Related]
13. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
14. Gamma interferon-mediated inflammation is associated with lack of protection from intravaginal simian immunodeficiency virus SIVmac239 challenge in simian-human immunodeficiency virus 89.6-immunized rhesus macaques.
Abel K; La Franco-Scheuch L; Rourke T; Ma ZM; De Silva V; Fallert B; Beckett L; Reinhart TA; Miller CJ
J Virol; 2004 Jan; 78(2):841-54. PubMed ID: 14694116
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV.
Martinez-Navio JM; Fuchs SP; Mendes DE; Rakasz EG; Gao G; Lifson JD; Desrosiers RC
Front Immunol; 2020; 11():449. PubMed ID: 32256496
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic dendritic-cell vaccine for simian AIDS.
Lu W; Wu X; Lu Y; Guo W; Andrieu JM
Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of protection against simian immunodeficiency virus infection.
Johnson RP
Vaccine; 2002 May; 20(15):1985-7. PubMed ID: 11983259
[TBL] [Abstract][Full Text] [Related]
20. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination.
Finnefrock AC; Tang A; Li F; Freed DC; Feng M; Cox KS; Sykes KJ; Guare JP; Miller MD; Olsen DB; Hazuda DJ; Shiver JW; Casimiro DR; Fu TM
J Immunol; 2009 Jan; 182(2):980-7. PubMed ID: 19124741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]